Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma
贝伐单抗、奥沙利铂和吉西他滨治疗复发性苗勒氏管癌的 II 期研究的安全性、有效性和生物标志物探索
期刊:Clin Ovarian Cancer Other Gynecol Malig
影响因子:
doi:10.1016/j.cloc.2011.04.003
Neil S Horowitz, Richard T Penson, Dan G Duda, Emmanuelle di Tomaso, Yves Boucher, Marek Ancukiewicz, Kenneth S Cohen, Suzanne Berlin, Carolyn N Krasner, Marsha A Moses, Rakesh K Jain
